Lake Forest Park, WA, United States of America

Claes Olof Bavik

This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Acucela Inc.. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claes Olof Bavik. Retrieved from https://idiyas.com/inventor/claes-olof-bavik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Bothell, WA (US) (2019)
  • Lake Forest Park, WA (US) (2018 - 2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Claes Olof Bavik

Introduction

Claes Olof Bavik is a notable inventor based in Lake Forest Park, WA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of diabetic retinopathy and other related diseases. With a total of four patents to his name, Bavik's work has the potential to impact many patients suffering from various ophthalmic conditions.

Latest Patents

Bavik's latest patents focus on methods for the treatment of diabetic retinopathy and other ophthalmic diseases. These methods provide innovative approaches for treating conditions associated with diabetes in patients. Additionally, they include treatments for retinopathy of prematurity and wet age-related macular degeneration. The methods involve the administration of specific compounds that aim to inhibit or slow the progression of symptoms related to these conditions.

Career Highlights

Claes Olof Bavik has established himself as a key figure in his field through his work at Acucela Inc. His dedication to advancing ophthalmic treatments has garnered attention and respect within the medical community. His innovative approaches have the potential to change the lives of many patients suffering from debilitating eye conditions.

Collaborations

Bavik collaborates with esteemed colleagues such as Ryo Kubota and Susan Hayes Henry. Their combined expertise contributes to the development of effective treatments and enhances the research efforts at Acucela Inc.

Conclusion

Claes Olof Bavik's contributions to ophthalmology through his patents and collaborative efforts highlight his commitment to improving patient care. His innovative methods for treating diabetic retinopathy and other ophthalmic diseases represent a significant advancement in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…